Mesa Laboratories - MLAB Stock Forecast, Price & News

0 Wall Street analysts have issued 12 month price targets for Mesa Laboratories' shares. Their MLAB share price forecasts range from $166.00 to $166.00. On average, they anticipate the company's share price to reach $166.00 in the next year. This suggests that the stock has a possible downside of 17.3%.
View analysts price targets for MLAB or view top-rated stocks among Wall Street analysts.

Mesa Laboratories' stock was trading at $166.21 at the beginning of the year. Since then, MLAB shares have increased by 20.8% and is now trading at $200.74.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Monday, February 6th 2023.
View our MLAB earnings forecast.

Mesa Laboratories, Inc. (NASDAQ:MLAB) released its earnings results on Monday, May, 31st. The medical instruments supplier reported $0.74 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.91 by $0.17. The medical instruments supplier had revenue of $37.96 million for the quarter, compared to analysts' expectations of $34.92 million. Mesa Laboratories had a negative net margin of 1.78% and a positive trailing twelve-month return on equity of 6.71%.

Mesa Laboratories declared a quarterly dividend on Tuesday, January 3rd. Investors of record on Tuesday, February 28th will be paid a dividend of $0.16 per share on Wednesday, March 15th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.32%. The ex-dividend date of this dividend is Monday, February 27th.
Read our dividend analysis for MLAB.

Mesa Laboratories (NASDAQ:MLAB) pays an annual dividend of $0.64 per share and currently has a dividend yield of 0.33%.
Read our dividend analysis for MLAB.

5 employees have rated Mesa Laboratories Chief Executive Officer Gary Owens on Glassdoor.com. Gary Owens has an approval rating of 51% among the company's employees. This puts Gary Owens in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Mesa Laboratories investors own include NVIDIA (NVDA), Verizon Communications (VZ), Intel (INTC), Alibaba Group (BABA), Altria Group (MO), Micron Technology (MU), Exxon Mobil (XOM), AbbVie (ABBV), Advanced Micro Devices (AMD) and Becton, Dickinson and (BDX).

Mesa Laboratories trades on the NASDAQ under the ticker symbol "MLAB."

Mesa Laboratories' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Conestoga Capital Advisors LLC (10.76%), Comerica Bank (0.94%), Rice Hall James & Associates LLC (0.27%), Moody Aldrich Partners LLC (0.21%), Yousif Capital Management LLC (0.06%) and Exchange Traded Concepts LLC (0.06%). Insiders that own company stock include Brian David Archbold, David M Kelly, Evan Guillemin, Gary M Owens, Gregory Dinoia, John Bradley Schmieder, John James Sullivan, John Sakys, Robert V Dwyer and Shannon Hall.
View institutional ownership trends.

Shares of MLAB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of MLAB stock can currently be purchased for approximately $200.74.

Mesa Laboratories (NASDAQ:MLAB) has a market capitalization of $1.07 billion and generates $184.34 million in revenue each year. The medical instruments supplier earns $1.87 million in net income (profit) each year or ($0.76) on an earnings per share basis.

The company employs 506 workers across the globe.

Mesa Laboratories' mailing address is 12100 W 6TH AVE, LAKEWOOD CO, 80228. The official website for the company is www.mesalabs.com. The medical instruments supplier can be reached via phone at (303) 987-8000, via email at investorrelations@mesalabs.com, or via fax at 303-987-8989.